Corcept Therapeutics
Biotechnology ResearchView the employees at
Corcept Therapeutics-
April Zitlau Accomplished Account Manager Producing Quality Outcomes
-
San Francisco Bay Area
-
Rising Star
Scott Hugill Associate Director - Analytical Development at Corcept Therapeutics-
Top 10%
Sally Smikahl Senior Director, Regulatory Affairs at Corcept Therapeutics-
San Mateo, California, United States
-
Top 5%
Susan Welch Rare Disease Clinical Sales Specialist-
Orlando, Florida, United States
-
Top 10%
Lorne Cheeseman Senior Director, Clinical Quality Assurance at Corcept Therapeutics-
Menlo Park
-
Top 5%
Overview
Leading the field in the discovery of drugs that modulate the effects of cortisol. The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
-